Effective omalizumab interval prolongation in the treatment of chronic urticaria

Alizadeh Aghdam, Mehran; Pieterse, Rianne Henriëtte; Kentie, Petra Adriana; Rijken, Feiko; Knulst, André Cornelis; Röckmann, Heike

doi:https://doi.org/10.1016/j.jaip.2020.06.056

Effective omalizumab interval prolongation in the treatment of chronic urticaria

DSpace/Manakin Repository

Effective omalizumab interval prolongation in the treatment of chronic urticaria

Alizadeh Aghdam, Mehran; Pieterse, Rianne Henriëtte; Kentie, Petra Adriana; Rijken, Feiko; Knulst, André Cornelis; Röckmann, Heike

(2020) Journal of Allergy and Clinical Immunology: In Practice, volume 8, issue 10, pp. 3667 - 3668.e1

(Letter)

Download/Full Text

Open Access version via Utrecht University Repository

Publisher version

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Immunology and Allergy, Journal Article

DOI: https://doi.org/10.1016/j.jaip.2020.06.056

ISSN: 2213-2198

Publisher: Elsevier

Note: Funding Information: No funding was received for this work. Conflicts of interest: A. C. Knulst is a member of advisory board of Novartis; and has health care innovation grant from Novartis to institution. H. Röckmann is a member of national advisory board of Novartis. The rest of the authors declare that they have no relevant conflicts of interest.

(Peer reviewed)